Tissue-specific reprogramming of glutamine metabolism maintains tolerance to sepsis.
Reprogramming metabolism is of great therapeutic interest for reducing morbidity and mortality during sepsis-induced critical illness. Disappointing results from randomized controlled trials targeting glutamine and antioxidant metabolism in patients with sepsis have begged a deeper understanding of...
| Published in: | PLoS ONE |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-01-01
|
| Online Access: | https://doi.org/10.1371/journal.pone.0286525 |
